Trial Profile
Confocal Analysis of Corneal Structures of Symptomatic Allergic Conjunctivitis Patients Pre and Post Treatment With Olopatadine HCL Ophthalmic Solution, 0.2%
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Apr 2015
Price :
$35
*
At a glance
- Drugs Olopatadine (Primary)
- Indications Allergic conjunctivitis
- Focus Therapeutic Use
- Sponsors Alcon
- 27 Apr 2015 New trial record